Calcagni ML, Mattoli MV, Blasi MA, Petrone G, Sammarco MG, Indovina L, et al
Availble from Robinson MF, Damjanov N, Stamenkovic B, Radunovic G, Kivitz A, Cox L, Manukyan Z, Banfield C, Saunders M, Chandra D, Vincent MS, Mancuso J, Peeva E, Beebe JS (2020) Efficacy and safety of PF-06651600 (ritlecitinib), a novel JAK3/TEC inhibitor, in patients with moderate-to-severe rheumatoid arthritis and an inadequate response to methotrexate
This makes it a much more effective option than standard oral powders or capsules
Fromson, J
IL-22 has been shown to alleviate DSS-induced colitis by upregulating lncRNA-UCL expression [84]
Nevertheless, a more detailed mechanistic evaluation is necessary to understand the genetic and environmental roles of microbial immunomodulation and adaptive immunity in the etiology of PD